Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report

BACKGROUND: Postprandial hyperlipidemia impairs endothelial function and participates in the development of atherosclerosis. We investigated the postprandial effects of a dipeptidyl peptidase IV inhibitor, alogliptin, on endothelial dysfunction and the lipid profile. METHODS: A randomized cross-over...

Descripción completa

Detalles Bibliográficos
Autores principales: Noda, Yoko, Miyoshi, Toru, Oe, Hiroki, Ohno, Yuko, Nakamura, Kazufumi, Toh, Norihisa, Kohno, Kunihisa, Morita, Hiroshi, Kusano, Kengo, Ito, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557163/
https://www.ncbi.nlm.nih.gov/pubmed/23298374
http://dx.doi.org/10.1186/1475-2840-12-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557163/
https://www.ncbi.nlm.nih.gov/pubmed/23298374
http://dx.doi.org/10.1186/1475-2840-12-8

Ejemplares similares